特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

COVID-19ワクチン・治療薬のパイプライン分析:2020年

COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020

発行 The Business Research Company 商品コード 950444
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
COVID-19ワクチン・治療薬のパイプライン分析:2020年 COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020
出版日: 2020年07月17日 ページ情報: 英文 200 Pages
概要

当レポートでは、COVID-19ワクチン・治療薬の世界市場について調査分析し、市場の特徴・規模・成長率・セグメンテーション、地域別・国別分析、競合情勢、市場動向と戦略について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 疾患の概要

  • 新型コロナウイルスの病因・病原
  • COVID-19の臨床的特徴:兆候と症状

第3章 主要国の疾患の疫学と流行統計

第4章 世界のCOVID-19治療薬・ワクチンのパイプライン分析

  • 世界のパイプライン分析:製品タイプ別
    • 低分子
    • 生物製剤
  • 世界のパイプライン分析:開発のフェーズ別
    • 前臨床の治療薬・ワクチン
    • 臨床試験
  • 世界のパイプライン分析:治療の機序・投与経路別
    • 作用機序
    • 投与経路
  • 世界のパイプライン分析:スポンサーの種類別
    • 製薬/バイオテクノロジー企業
    • 学術研究/機関
    • その他 (政府機関・CROなど)

第5章 後期開発の治療薬・ワクチンの競合情勢

  • 企業概要
  • 製品説明
  • 研究開発
  • ライセンス・提携契約
  • マイルストーン・将来の計画

第6章 COVID-19治療薬・ワクチンのマーケティング承認に対する規制の枠組み

  • 米国の規制の枠組み
  • EU・その他の国の規制の枠組み

第7章 提言と結論

目次

COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global covid19 vaccine & therapeutics pipeline analysis 2020 market.

This report focuses on covid19 vaccine & therapeutics pipeline analysis 2020 market which is experiencing strong growth. The report gives a guide to the covid19 vaccine & therapeutics pipeline analysis 2020 market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the covid19 vaccine & therapeutics pipeline analysis 2020? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The COVID19 Vaccine & Therapeutics Pipeline Analysis 2020 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider covid19 vaccine & therapeutics pipeline analysis 2020 market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The covid19 vaccine & therapeutics pipeline analysis 2020 market section of the report gives context. It compares the covid19 vaccine & therapeutics pipeline analysis 2020 market with other segments of the covid19 vaccine & therapeutics pipeline analysis 2020 market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, covid19 vaccine & therapeutics pipeline analysis 2020 indicators comparison.

Scope

Markets Covered:

1) By Product Type: Small Molecules, Biologics, Blood & Plasma Derivatives, Monoclonal Antibodies, Vaccines, Others

2) By Phase Of Development: Preclinical Therapeutics & Vaccines, Clinical Studies

3) By Treatment Mechanism & Route Of Administration: Mechanism Of Action And By Route Of Administration

4) By Type Of Sponsor: Pharma/Biotech Company, Academic Research/Institution, Others (such as Government Organizations and CROs)

Companies Mentioned: CanSino Biologics; Moderna; Inovio Pharmaceuticals; Regeneron; Gilead Sciences

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Disease Overview

  • 2.1. Novel Coronavirus Etiology and Pathogenesis
  • 2.2. Novel Human Coronavirus (ClOVID-19) Clinical Features-Signs and Symptoms

3. Disease Epidemiology and Epidemic Statistics for Major countries

4. Global Pipeline Analysis of COVID-19 Therapeutics and Vaccines

  • 4.1 Global Pipeline Analysis, By Product Type
    • 4.1.1 Small Molecules
    • 4.1.2 Biologics
      • 4.1.2.1 Blood & Plasma Derivatives
      • 4.1.2.2 Monoclonal Antibodies
      • 4.1.2.3 Vaccines
      • 4.1.2.4 Others
  • 4.2 Global Pipeline Analysis, By Phase of development
    • 4.2.1 Preclinical Therapeutics & Vaccines
    • 4.2.2 Clinical Studies
      • 4.2.2.1 Clinical Phase I, II, III
  • 4.3 Global Pipeline Analysis, By Treatment Mechanism & Route of Administration
    • 4.3.1 Mechanism of Action
      • 4.3.1.1 Viral Replication Inhibitors
      • 4.3.1.2 Protease Inhibitors
      • 4.3.1.3 Immunostimulants
      • 4.3.1.4 Other Mechanism of Action
    • 4.3.2 Route of Administration
      • 4.3.2.1 Oral
      • 4.3.2.2 Intravenous
      • 4.3.2.3 Subcutaneous
      • 4.3.2.4 Other Route of Administration
  • 4.4 Global Pipeline Analysis, By Type of Sponsor
    • 4.4.1 Pharma/Biotech Company
    • 4.4.2 Academic Research/Institution
    • 4.4.3 Others such as Government Organizations and CROs

5. Competitive Landscape for Late Stage Therapeutics and Vaccine

  • 5.1 Company Overview
  • 5.2 Product Description
  • 5.3 Research and Development
    • 5.3.1 Non-Clinical Studies
    • 5.3.2 Clinical Studies
    • 5.3.3 Highest/Late Stage Development Activities
  • 5.4 Licensing and Collaboration Agreements
  • 5.5 Milestones & Future Plans

6. Regulatory Framework for COVID-19 Therapeutics and Vaccines Marketing Approvals

  • 6.1 Regulatory Framework in the USA
  • 6.2 Regulatory Framework in EU and Other Countries

7. Recommendations & Conclusion